These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32611433)
1. Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database. Zhang C; Ma T J Ovarian Res; 2020 Jul; 13(1):75. PubMed ID: 32611433 [TBL] [Abstract][Full Text] [Related]
2. Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis. Pan X; Yang W; Wen Z; Li F; Tong L; Tang W J Gynecol Oncol; 2020 Nov; 31(6):e80. PubMed ID: 33078590 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis. Han Y; Wang J; Wang Z; Xu B Cancer Control; 2021; 28():10732748211044355. PubMed ID: 34654324 [TBL] [Abstract][Full Text] [Related]
4. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis. Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160 [TBL] [Abstract][Full Text] [Related]
5. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis. Abdel-Rahman O Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery. Li S; Zhu Z J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926 [TBL] [Abstract][Full Text] [Related]
7. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary. Wu H; Jiang S; Zhong P; Li W; Zhang S J Ovarian Res; 2021 Oct; 14(1):137. PubMed ID: 34674727 [TBL] [Abstract][Full Text] [Related]
8. Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database. Li X; Yang Q; Chen M; Yang C; Gu J; Dong Q; Yang G J Ovarian Res; 2021 Feb; 14(1):40. PubMed ID: 33640000 [TBL] [Abstract][Full Text] [Related]
9. Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma. Chiu MS; Verma V; Bennion NR; Bhirud AR; Li J; Charlton ME; Are C; Lin C Cancer Med; 2016 Dec; 5(12):3394-3402. PubMed ID: 27781400 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcomes of squamous ovarian carcinoma; a population-based study. Nasioudis D; Sisti G; Kanninen TT; Holcomb K; Di Tommaso M; Fambrini M; Witkin SS Gynecol Oncol; 2016 Apr; 141(1):128-33. PubMed ID: 26867989 [TBL] [Abstract][Full Text] [Related]
12. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Characteristic and Prognosis between Ovarian Clear Cell Carcinoma and Serous Carcinoma: A 10-Year Cohort Study of Chinese Patients. Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K PLoS One; 2015; 10(7):e0133498. PubMed ID: 26186453 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer. Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271 [TBL] [Abstract][Full Text] [Related]
15. Grading ovarian serous carcinoma using a two-tier system. Malpica A; Deavers MT; Lu K; Bodurka DC; Atkinson EN; Gershenson DM; Silva EG Am J Surg Pathol; 2004 Apr; 28(4):496-504. PubMed ID: 15087669 [TBL] [Abstract][Full Text] [Related]
16. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis. Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Transitional Cell Carcinoma-Like Morphology of High-Grade Serous Ovarian Carcinoma: A Comparative Study. Nasioudis D; Sisti G; Kanninen TT; Fambrini M; Di Tommaso M Int J Gynecol Cancer; 2016 Nov; 26(9):1624-1629. PubMed ID: 27575630 [TBL] [Abstract][Full Text] [Related]
18. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study. Hu D; Ma D; Zhang ZJ; Zhang Y; Huang K; Li X Front Endocrinol (Lausanne); 2023; 14():1103429. PubMed ID: 36742399 [TBL] [Abstract][Full Text] [Related]
19. Prognosis of bulky pTIIB cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching. Okadome M; Nagayama R; Shimokawa M; Sonoda K; Shimamoto K; Saito T Int J Gynaecol Obstet; 2021 Apr; 153(1):56-63. PubMed ID: 33119174 [TBL] [Abstract][Full Text] [Related]
20. The clinicopathological features and prognostic factors of gastric squamous cell carcinoma. Dong C; Jiang M; Tan Y; Kong Y; Yang Z; Zhong C; Li D; Yuan Y Medicine (Baltimore); 2016 Aug; 95(34):e4720. PubMed ID: 27559983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]